The Buck Institute for Research on Aging in Novato, California, has announced gifts totaling $10 million from members of its board of trustees.
The gifts will bolster the institute's work in aging research and on novel therapeutic interventions by enabling it to hire additional faculty, fund upgrades to laboratories and equipment, and invest in new scientific collaborations. The funding also will support the hiring of Eric M. Verdin, a world-renowned expert on aging research, as the institute's president and CEO.
Verdin, a professor of medicine at the University of California, San Francisco, joins the institute from the Gladstone Institute for Virology and Immunology, where he served as associate director and senior investigator, with a focus on the role of metabolism and diet in aging as well as the chronic diseases of aging, including Alzheimer's. A native of Belgium, he received his doctorate from the University of Liege and additional clinical and research training at Harvard Medical School.
"Today marks a true milestone at the Buck and an incredible investment in our future," said Buck Institute board chair Larry Rosenberger. "The appointment of Eric to head this institute reinforces our position as a leading player on the world's scientific stage and will enable us to expand upon the Buck's global leadership in geroscience. I would characterize the $10 million funding commitment by our board of trustees and the hiring of Eric as the basis for creating our future."